SubPennyTrader

1.4K posts

SubPennyTrader

SubPennyTrader

@SubPennyTrader

Focusing on stocks under a dime…maybe a few dolla plays now and then. Playing news/current events, volume spikes and dip opps. All advice is opinion only.

Merica Katılım Ağustos 2016
321 Takip Edilen126 Takipçiler
Sabitlenmiş Tweet
SubPennyTrader
SubPennyTrader@SubPennyTrader·
Always playing high daily volume… have to be able to sell to make a profit!
English
1
0
7
0
SubPennyTrader
SubPennyTrader@SubPennyTrader·
$CHOW off and running 🚀
English
0
0
2
54
SubPennyTrader retweetledi
i_like_bb_stock
i_like_bb_stock@thommic·
$CHOW gonna rocket at some pt. and join the china runners $GMM $HAO $CHSN $ZBAO
English
2
1
5
2.4K
buysellshort.net
buysellshort.net@buysellshort·
$CPHI blowin up naked shorts again check out $JZXN same naked shorts low float china
English
3
0
6
5.2K
SubPennyTrader retweetledi
Cheep
Cheep@cheep_trades·
keep an eye on $chow with these chinas going
English
0
2
10
447
SubPennyTrader retweetledi
Small Cap GOAT
Small Cap GOAT@smallcapgoat·
$CHOW time soon
Small Cap GOAT tweet media
English
0
2
4
381
SubPennyTrader retweetledi
i_like_bb_stock
i_like_bb_stock@thommic·
watch $CHOW here last time it went to .60 AH
English
0
2
7
949
Gage
Gage@BawzRs·
Some chinas had some 500k share bidders before close interested if they get ran soon
English
1
0
4
846
SubPennyTrader retweetledi
BullishBubba
BullishBubba@BullishBubba·
$LIMN frisky today
English
0
1
2
241
SubPennyTrader retweetledi
DragonTailz
DragonTailz@DragonTails51·
$LIMN $LIMN merged with INNOCS AI LLC. It now owns a Phase‑2 oncology program. It has a CD47 checkpoint inhibitor. It has an AI‑enhanced oncology platform. Sector valuations for similar companies are $100M–$450M. Its current market cap ($5–7M) is completely wrong. Volume behavior shows repricing is starting. No active dilution. Shorts are misaligned. The market is still pricing the old shell. Thoughts?
English
1
1
5
2.4K
SubPennyTrader retweetledi
REXOM
REXOM@smith_will86715·
$LIMN 0.40 next leg: $320M merger: Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline. BOOM
English
0
1
2
495
SubPennyTrader retweetledi
DragonTailz
DragonTailz@DragonTails51·
$LIMN $5.00 stock potential?
English
0
3
7
864
SubPennyTrader retweetledi
DragonTailz
DragonTailz@DragonTails51·
@Banancial $LIMN merged with INNOCS AI LLC. It now owns a Phase‑2 oncology program. It has a CD47 checkpoint inhibitor. It has an AI‑enhanced oncology platform. Sector valuations for similar companies are $100M–$450M. Its current market cap ($5–7M) is completely wrong. Volume behavior shows repricing is starting. No active dilution. Shorts are misaligned. The market is still pricing the old shell. Thoughts?
English
1
1
2
581
John Porter
John Porter@John_Porter10·
After hours fire 🔥 list🔥👀👀 $LIMN $VSEE $JTAI $TGHL $PMI Stay tuned everyone 👀
English
1
0
0
448
John Porter
John Porter@John_Porter10·
Also, I am holding full position $LIMN and $VSEE position overnight If you all are ready please 🙏 hit me a like 👍 down below 👇
English
2
0
4
771
SubPennyTrader retweetledi
Hustle4Life
Hustle4Life@InHisHandsAlone·
$LIMN .12 with 105 million in volume. High .14 today looks ready for next leg. Volume before price always. Gapper?
GIF
English
2
1
6
1.3K
SubPennyTrader retweetledi
REXOM
REXOM@smith_will86715·
$CPHI big run. next $LIMN merger
English
0
1
2
666
Tom White
Tom White@stevenjones911·
$LIMN crashed sharply to an extreme single-session high of $0.3650 driven by short-term speculative biotech hype, then heavy profit-taking triggered a sustained bearish downtrend with consistent lower swing highs afterward.
Tom White tweet media
English
1
0
1
663
SubPennyTrader retweetledi
REXOM
REXOM@smith_will86715·
$LIMN new $SOBR ww
English
0
1
1
472
SubPennyTrader
SubPennyTrader@SubPennyTrader·
Volume comes in let’s go $1 plus 🚀 $TGE
English
0
0
1
35